Skip to content

PROK - PROKIDNEY CORP. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchP

ProKidney Corp.

PROK · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

P

PROKProKidney Corp.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $3.48
52-wk low: $1.30
Prev close: $2.43
Mkt cap: $590.8M
Beta: 1.72
P/S: 722.2x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$21.9M

JS
Jim Simons
Q2 2026 13F
$2.2M
position
MI
Millennium
Israel Englander · Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 15.4% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $591M

Valuation

P/S722.24
P/B97.15

Quality

Operating margin-32249.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: PROK
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $590.79M
Beta: 1.72

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

97.2x

Profit margin

+0.0%

Op margin

-32249.0%

ROE

-59.0%

$2.2M

position

MW

Marshall Wace

Q1 2026 13F

$1.8M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for PROK

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.15-15.4%

-$0.13 expected

Next report

What the street expects next

EPS expected

-$0.14

-$0.17 to -$0.12

Revenue expected

$99.8K

5 analysts

Last 30 days

3up0down

Analysts raising estimates

-59.0%

ROA-35.7%

Growth

Beta1.72